RPRX - Repros Therapeutics Stock Trading
Repros Therapeutics Inc. Company Name:
RPRX Stock Symbol:
NASDAQ Market:
Repros Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
New capital deployment target of $10-12 billion over the next five years Outlook for 2020-2025 Adjusted Cash Receipts (1) (non-GAAP) CAGR raised to 11-14% Adjusted Cash Receipts (1) (non-GAAP) expected to grow 10% or more over this decade, positio...
-
Image source: The Motley Fool. Royalty Pharma plc (NASDAQ: RPRX) Q1 2022 Earnings Call May 05, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Royalty Pharma plc (RPRX) Q1 2022 Earnings Call Transcript
-
Net cash provided by operating activities (GAAP) of $460 million; Adjusted Cash Receipts ( 1) (non-GAAP) of $605 million Announced transactions of up to $450 million in Q1 2022 2022 guidance reaffirmed: Adjusted Cash Receipts (1) e...